| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914903 | Molecular Oncology | 2012 | 7 Pages |
Abstract
⺠Cancer biomarkers must undergo rigorous analytic and clinical validation. ⺠Clinical validity must be established before a biomarker is used in the clinic. ⺠Guidelines have been established for reporting results of tumor marker studies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
N. Lynn Henry, Daniel F. Hayes,